Advertisement

Health


Healthcare startup Kismet secures $8.2m after year of rapid growth

Healthcare startup Kismet secures $8.2m after year of rapid growth

Melbourne-based healthcare startup Kismet has secured $8.2 million ...

Vitamin delivery startup Vitable raises $7.5m and plans crowdfunded supplement

Vitamin delivery startup Vitable raises $7.5m and plans crowdfunded supplement

One of Australia's fastest-growing online vitamin brands Vitabl...

Navi raises $2.4m to develop precision med-tech for treating critically ill babies

Navi raises $2.4m to develop precision med-tech for treating critically ill babies

Melbourne-based startup Navi Medical Technologies has successfully ...

Tesla chair Robyn Denholm joins Harrison.ai board

Tesla chair Robyn Denholm joins Harrison.ai board

One of Australia's most promising founder-led tech scale-ups Ha...

Antioxidant supplements scale-up Renovatio bags $5m Coles deal

Antioxidant supplements scale-up Renovatio bags $5m Coles deal

An Indonesian-born scientist, whose PhD at the University of Newcas...

Advertisement
Advertisement
Advertisement
4DMedical CEO sees 'immediate' opportunities to commercialise newly unveiled lung scanner

4DMedical CEO sees 'immediate' opportunities to commercialise newly unveiled lung scanner

Following a battering of health tech stocks in early 2022, Melbourn...

Kin Fertility: Meet the company behind #WeNeedMoreLeave

Kin Fertility: Meet the company behind #WeNeedMoreLeave

Sydney-based women’s health platform Kin Fertility is spearhe...

Cann finally finishes Mildura greenhouse with key cannabis cultivation permit

Cann finally finishes Mildura greenhouse with key cannabis cultivation permit

Three years after first acquiring the site in Mildura in Victo...

Cochlear-backed Epiminder raises $16m to expand epilepsy monitoring device trials

Cochlear-backed Epiminder raises $16m to expand epilepsy monitoring device trials

Aiming to revolutionise the lives of millions of people who suffer ...

Virtus board agrees to $706m CapVest takeover

Virtus board agrees to $706m CapVest takeover

After three months of bids, the board of in-vitro fertilisation (IV...

Why healthtech Maslow is on a mission to transform Australian disability care

Why healthtech Maslow is on a mission to transform Australian disability care

Seven years ago, a friend of Andrew Akib had his life change instan...

One million scripts a week: Two leading independent pharmacy groups to merge

One million scripts a week: Two leading independent pharmacy groups to merge

Two of Australia's largest independent pharmacy networks have a...

Medtech designed to calm needle-phobes pokes into Australian hospitals

Medtech designed to calm needle-phobes pokes into Australian hospitals

The company behind a medical device designed to relieve the physica...

How HotDoc is shaping the Australian patient experience

How HotDoc is shaping the Australian patient experience

"I think I'm the kind of person who was always a little bi...

BGH Group ups Virtus Health takeover bid to $653m

BGH Group ups Virtus Health takeover bid to $653m

After successfully preventing rival suitor CapVest from entering a ...

Omicron infects Healthia's bottom line

Omicron infects Healthia's bottom line

Allied health company Healthia (ASX: HLA) has seen its December hal...

Medicinal cannabis player Incannex lights up US boards with Nasdaq listing

Medicinal cannabis player Incannex lights up US boards with Nasdaq listing

Melbourne-based medicinal cannabis product developer Incannex (ASX:...

Australian Clinical Labs lifts profit six-fold on prospectus forecast at $130m

Australian Clinical Labs lifts profit six-fold on prospectus forecast at $130m

Australian Clinical Labs (ASX: ACL) has been collecting both swabs ...

COVID testing demand means record result for Sonic Healthcare, but market sniffles on outlook

COVID testing demand means record result for Sonic Healthcare, but market sniffles on outlook

Shares in Sonic Healthcare (ASX: SHL) have dropped 4 per cent today...

Needle-free vaccine developer Vaxxas aims to shake up centuries-old immunisation methods

Needle-free vaccine developer Vaxxas aims to shake up centuries-old immunisation methods

A $600,000 co-investment from the Federal Government is expected to...

Advertisement

Partner Content

Ask any parent, and they’ll tell you: preparing for a new bab...
The time is ripe to get serious about digital transformation, make ...
Ambitious business owners and entrepreneurs always have one eye on ...
Pavilion Founder and CEO Sam Jacobs believes board members should u...
Eight years after launching Aircall, we have recently achieved a US...
In Australia, three things are certain: death, taxes, and backyard ...
Warnings from business leaders across Australia, including Coles CE...
Ram Charan, a corporate governance expert and bestselling author of...
Advertisement